Lakers Co-Owner Working on Oral COVID-19 Vaccine - TMZ

Patrick Soon-Shiong is the founder of ImmunityBio as well as a Lakers co-owner, and his company is behind the tests being done at a research center in El Segundo, CA to determine if a series of pills can replace injections to inoculate the population.

Soon-Shiong says the value of ImmunityBio's vaccine is that it generates "killer T cells" that target the center of the coronavirus, which is less prone to mutation.

the Lakers co-owner believes capsules and injections working together would be key.